Obstetrics & Gynecology Email Alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Obstetrics & Gynecology 1978;52:100-104
© 1978 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by STEVEN PIVER, M.
Right arrow Articles by LELE, S. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by STEVEN PIVER, M.
Right arrow Articles by LELE, S. B.

Incidence of Subclinical Metastasis in Stage I and II Ovarian Carcinoma

M. STEVEN PIVER, MD, FACOG, JOSEPH J. BARLOW, MD, FACOG and SHASHIKANT B. LELE, MD

From the Department of Gynecologic Oncology at Roswell Park Memorial Institute, Buffalo, New York

Abstract

The incidence of unsuspected metastasis to the diaphragm, retroperitoneal lymph nodes, and omentum as well as malignant cytologic peritoneal washings in women with presumed localized ovarian cancer is presented. Of the women with presumed Stage I ovarian cancer, from our clinical experience and those reported in the literature, 11.3% were found to have diaphragmatic metastases, 13.3% had aortic lymph node metastases, 8.1% had pelvic lymph node metastases, 3.2% had omental metastases, and 32.9% had malignant peritoneal washings. In Stage II ovarian cancer, 23% were found to have diaphragmatic metastases, 10.0% had aortic lymph node metastases, 0% had omental metastases, and 12.5% had malignant peritoneal washings.




This article has been cited by other articles:


Home page
 NEJMHome page
F. V. Price, R. T. Penson, D. Sahani, and D. A. Bell
Case 37-2004: Postmenopausal Bleeding and a Cystic Ovarian Mass
N. Engl. J. Med., March 24, 2005; 352(12): 1269 - 1270.
[Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
ICON1 and EORTC-ACTION
International Collaborative Ovarian Neoplasm Trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm Trial: Two Parallel Randomized Phase III Trials of Adjuvant Chemotherapy in Patients With Early-Stage Ovarian Carcinoma
J Natl Cancer Inst, January 15, 2003; 95(2): 105 - 112.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1978 by the American College of Obstetricians and Gynecologists.